Medicare Enrolled

Dr. Robert Flavell, MD

Radiation Oncology · New York, NY
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Consulting-driven
1275 YORK AVE, New York, NY 10065
2126396942
In practice since 2010 (15 years)
NPI: 1821306879 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Flavell from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Flavell? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Flavell

Dr. Robert Flavell is a radiation oncology specialist in New York, NY, with 15 years of NPI registration. Based on federal Medicare data, Dr. Flavell performed 7,966 Medicare services across 930 unique beneficiaries.

Between the years covered by Open Payments, Dr. Flavell received a total of $2,214 from 2 pharmaceutical and/or device companies across 10 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in radiation oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Flavell is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 15 years in practice ▲ Top 20% volume in NY $2,214 industry payments

Medicare Practice Summary

Medicare Utilization ↗
7,966
Medicare services
Top 20% in NY for radiation oncology
930
Unique beneficiaries
$14
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~531 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Contrast dye for imaging (iodine-based)
A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures.
7,058 $0 $9
Nuclear medicine scan from skull base to mid-thigh with CT
A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan.
174 $129 $1,940
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries 156 $283 $2,804
Nuclear medicine scan, skull base to mid-thigh
A nuclear medicine imaging study that captures images from the base of the skull down to the middle of the thigh.
116 $80 $1,868
Nuclear stress test of heart muscle
A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera.
84 $66 $2,447
CT scan of chest with contrast
A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures.
70 $53 $1,501
CT scan of abdomen and pelvis with contrast
A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas.
62 $90 $2,256
Whole body bone and joint nuclear medicine scan
A nuclear medicine imaging test that uses a radioactive tracer to create pictures of the entire skeleton and joints. This scan helps evaluate bone health and detect abnormalities throughout the body.
47 $34 $1,447
SPECT/CT nuclear medicine scan, multiple areas
A combined nuclear medicine and CT imaging study performed on at least two body areas or through separate acquisitions on the same day.
46 $87 $605
Whole body nuclear medicine scan with CT
A combined imaging procedure using nuclear medicine and CT scans to visualize the entire body.
42 $103 $2,523
Radioactive drug therapy through a vein
Administration of a radioactive medication directly into the bloodstream via an intravenous line.
41 $85 $1,427
Whole body nuclear medicine scan
A diagnostic imaging test that uses a small amount of radioactive material to create pictures of the entire body. The procedure helps doctors evaluate how organs and tissues are functioning.
37 $79 $2,289
Thyroid nuclear medicine study
A diagnostic imaging test using radioactive material to evaluate the structure and function of the thyroid gland.
11 $19 $2,764
Lung ventilation and perfusion scan
A nuclear medicine test that uses radioactive tracers to evaluate both air flow (ventilation) and blood flow (perfusion) in the lungs.
11 $41 $3,748
SPECT nuclear medicine scan, 1 area
A nuclear medicine imaging test using a single photon emission computed tomography (SPECT) scan to create detailed images of one specific area of the body.
11 $41 $1,228
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.1% high complexity
97.4% medium
2.5% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$2,214
Total received (2018-2024)
Avg $738/year across 3 years
Top 20% in NY for radiation oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
2
Companies
10
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,471 (66.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$743 (33.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,471
2019
$634
2018
$109

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Telix Pharmaceuticals
$1,471
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Telix Pharmaceuticals
$1,471
GENZYME CORPORATION
$743
Top 3 companies account for 100.0% of all-time payments
Associated products mentioned in payments ›
ILLUCCIX · NO PRODUCT DISCUSSED
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (66%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.

Looking for a radiation oncology specialist in New York?
Compare radiation oncologists in the New York area by procedure volume, costs, and industry payment transparency.
Browse radiation oncologists nearby

Geographic Context

Radiation oncologists within 10 mi
2,044
Per 100K population
125.6
County median income
$104,553
Nearest hospital
NEW YORK-PRESBYTERIAN HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Flavell is a mixed practice specialist, with above-average Medicare volume (top 20% in NY), with consulting-driven industry engagement in the top 20% of NY peers, with 15 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Flavell experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Flavell performed 7,058 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Flavell receive payments from pharmaceutical companies?
Yes. Dr. Flavell received a total of $2,214 from 2 companies across 10 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Flavell's costs compare to other radiation oncologists in New York?
Dr. Flavell's average Medicare payment per service is $14. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Flavell) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →